loading...| Preferred Name | bendroflumethiazide | |
| Synonyms |
bendrofluazide Aprinox BTZ |
|
| Definitions |
A condition in which the main influencing factor is bendroflumethiazide, a sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0000862 |
|
| created_by |
slaulede |
|
| creation_date |
2021-07-06T17:28:01Z |
|
| database_cross_reference |
PMID:18480177 |
|
| definition |
A condition in which the main influencing factor is bendroflumethiazide, a sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. |
|
| has_exact_synonym |
bendrofluazide Aprinox BTZ |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0000862 |
|
| label |
bendroflumethiazide |
|
| notation |
XCO:0000862 |
|
| prefLabel |
bendroflumethiazide |
|
| treeView | ||
| subClassOf |